Insider filing
Traded Sep 9 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Planned for Sep 9, 2026 · Notice filed Sep 9, 2026
A Lam Research officer told the SEC about a plan to sell $9.58M of Lam Research shares around Sep 9, 2026. The filing says the shares were acquired as compensation.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider filing
Traded Sep 9 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Timothy Archer (President and CEO) sold ~$9.58M of Lam Research
Planned saleInsider filing
Traded Sep 9 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade. A share price line is a session where the close moved at least 10% and four times its usual daily change.
The company's last weighty Form 8-K report up to this date: changed a top executive or board member, 16 days earlier (Aug 24, 2026). The first one after it: reported its results, 42 days later (Oct 21, 2026).